Cargando…

(18)F-Fluorocholine PET and 4D-CT in Patients with Persistent and Recurrent Primary Hyperparathyroidism

Patients with primary hyperparathyroidism (pHPT) can develop persistent (P-pHPT) or recurrent (R-pHPT) disease after parathyroidectomy. Before recommending reoperation, recurrence must be accurately identified because of the high risk of complications. Our study evaluates (18)F-fluorocholine ((18)F-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Latge, Adrien, Riehm, Sophie, Vix, Michel, Bani, Jacob, Ignat, Mihaela, Pretet, Valentin, Helali, Mehdi, Treglia, Giorgio, Imperiale, Alessio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700343/ https://www.ncbi.nlm.nih.gov/pubmed/34943620 http://dx.doi.org/10.3390/diagnostics11122384

Ejemplares similares

(18)F-Fluorocholine PET and Multiphase CT Integrated in Dual Modality PET/4D-CT for Preoperative Evaluation of Primary Hyperparathyroidism
por: Pretet, Valentin, et al.
Publicado: (2020)

Does (18)F-Fluorocholine PET/CT add value to positive parathyroid scintigraphy in the presurgical assessment of primary hyperparathyroidism?
por: Imperiale, Alessio, et al.
Publicado: (2023)

(18)F-Fluorocholine PET/CT Compared with Current Imaging Procedures for Preoperative Localization of Hyperfunctioning Parathyroids in Patients with Chronic Kidney Disease
por: Aymard, Samuel, et al.
Publicado: (2023)

Preoperative Imaging with [(18)F]-Fluorocholine PET/CT in Primary Hyperparathyroidism
por: Dekorsy, Franziska J., et al.
Publicado: (2022)

Incremental role of (18)F-fluorocholine PET/CT over technetium-99m-labeled MIBI scan in hyperparathyroidism
por: Behera, Abhishek, et al.
Publicado: (2016)

The Significance of 18F-Fluorocholine-PET/CT as Localizing Imaging Technique in Patients with Primary Hyperparathyroidism and Negative Conventional Imaging
por: Fischli, Stefan, et al.
Publicado: (2018)

High turnover renal osteodystrophy due to secondary hyperparathyroidism diagnosed by (18)F-Fluorocholine combined with (18)F-NaF PET/CT
por: Xiong, Lin, et al.
Publicado: (2021)

Detection of an undescended parathyroid adenoma with (18)F-fluorocholine PET/CT
por: Booij, J., et al.
Publicado: (2022)

Incidental Findings on (18) F-Fluorocholine PET/CT for Parathyroid Imaging
por: Broos, Wouter A.M., et al.
Publicado: (2022)

Parathyroid imaging with (18)F-fluorocholine PET/CT as a first-line imaging modality in primary hyperparathyroidism: a retrospective cohort study
por: Broos, Wouter A. M., et al.
Publicado: (2019)

Fluorocholine PET Imaging of Parathyroid Disease
por: Prabhu, Meghana, et al.
Publicado: (2018)

Two Birds with One Stone: Hepatocellular Carcinoma and Small Cell Lung Cancer Imaged with [(18)F]Fluorocholine Positron Emission Tomography/Computed Tomography
por: Cuzzocrea, Marco, et al.
Publicado: (2023)

(18)F-Fluorocholine PET/CT, Tc-99m-MIBI and TC-99m-MDP SPECT/CT in Tertiary Hyperparathyroidism with Renal Osteodystrophy
por: Ferrari, Cristina, et al.
Publicado: (2020)

Comparison of [(18)F]fluorocholine PET/CT with [(99)mTc]sestamibi and ultrasonography to detect parathyroid lesions in primary hyperparathyroidism: a prospective study
por: Manyalich-Blasi, Marti, et al.
Publicado: (2022)

Intra-vagal parathyroid adenoma on digital PET/CT with (18)F-fluorocholine
por: Mainta, Ismini C., et al.
Publicado: (2021)

Chronic Liver Disease and the Detection of Hepatocellular Carcinoma by [(18)F]fluorocholine PET/CT
por: Kwee, Sandi A., et al.
Publicado: (2015)

Optimal scan time for evaluation of parathyroid adenoma with [(18)F]-fluorocholine PET/CT
por: Rep, Sebastijan, et al.
Publicado: (2015)

Detection of Synchronous Parathyroid Adenoma and Breast Cancer with (18)F-Fluorocholine PET-CT
por: Vorselaars, Wessel MCM, et al.
Publicado: (2015)

Diagnostic accuracy of F-18-Fluorocholine PET/CT and multiparametric MRI for prostate cancer
por: Kim, Jung Kwon, et al.
Publicado: (2022)

Fluorine-18 Fluorocholine Positron Emission Tomography/Computed Tomography in Primary Hyperparathyroidism: A Case Report and Review of Literature
por: Ramalho, Diogo, et al.
Publicado: (2022)

Advantages of 18F-FDG PET/CT Imaging over Modified Duke Criteria and Clinical Presumption in Patients with Challenging Suspicion of Infective Endocarditis
por: Pretet, Valentin, et al.
Publicado: (2021)

Role of (18)Fluorocholine Positron Emission Tomography/Computed Tomography in the Localization of Culprit Lesions in Patients of Persistent/Recurrent Primary Hyperparathyroidism: A Prospective Study in COVID Times
por: Wakankar, Ritwik, et al.
Publicado: (2023)

Differentiation of hepatocellular adenoma and focal nodular hyperplasia using (18)F-fluorocholine PET/CT
por: van den Esschert, Jacomina W., et al.
Publicado: (2010)

Quantification of internal dosimetry in PET patients II: Individualized Monte Carlo‐based dosimetry for [18F]fluorocholine PET
por: Neira, Sara, et al.
Publicado: (2021)

Troubleshooting for F-18 Fluorocholine Synthesis: An Institutional Experience
por: Vatsa, Rakhee, et al.
Publicado: (2018)

Comparison of Neck Ultrasonography, Dual Phase (99m)Tc-Sestamibi with early SPECT-CT & (18)F-Fluorocholine PET-CT as First Line Imaging in Patients with Primary Hyperparathyroidism
por: Abhishek, Behera, et al.
Publicado: (2023)

Feasibility of (18)F-Fluorocholine PET for Evaluating Skeletal Muscle Atrophy in a Starved Rat Model
por: Park, Sun Mi, et al.
Publicado: (2022)

(18)F-FDOPA PET/CT Combined with MRI for Gross Tumor Volume Delineation in Patients with Skull Base Paraganglioma
por: Helali, Mehdi, et al.
Publicado: (2019)

(64)CuCl(2) PET Imaging of 4T1-Related Allograft of Triple-Negative Breast Cancer in Mice
por: Latgé, Adrien, et al.
Publicado: (2022)

Detection of recurrent prostate cancer with 18F-fluorocholine PET/CT in relation to PSA level at the time of imaging
por: Kwee, Sandi A., et al.
Publicado: (2012)

Visualization of Macroprolactinoma by (18)F-Fluorocholine PET/CT in a Patient With Multiple Endocrine Neoplasia Type 1
por: Paepegaey, Anne-Cécile, et al.
Publicado: (2018)

[(18)F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer
por: Pasqualetti, Francesco, et al.
Publicado: (2019)

Value of 18F-fluorocholine PET/CT in predicting response to radical radiotherapy in patients with localized prostate cancer
por: Sepulcri, Matteo, et al.
Publicado: (2021)

Hyperfunctioning parathyroid gland and skeletal involvement on [(18)F]fluorocholine PET/CT: one look with two views
por: Nappi, Carmela, et al.
Publicado: (2022)

Detection of recurrence sites using (18)F-fluorocholine PET/CT in prostate cancer patients with PSA failure
por: Kim, Dong-Yun, et al.
Publicado: (2023)

Kinetic analysis of dominant intraprostatic lesion of prostate cancer using quantitative dynamic [(18)F]DCFPyL-PET: comparison to [(18)F]fluorocholine-PET
por: Yang, Dae-Myoung, et al.
Publicado: (2021)

Radiation treatment monitoring using multimodal functional imaging: PET/CT ((18)F-Fluoromisonidazole & (18)F-Fluorocholine) and DCE-US
por: Arteaga-Marrero, Natalia, et al.
Publicado: (2015)

The role of (18)F-FDG PET for COVID-19 infection: myth versus reality
por: Treglia, Giorgio
Publicado: (2020)

Prognostic Value of (18)F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel
por: Quaquarini, E., et al.
Publicado: (2019)

Misleading localization by (18)F-fluorocholine PET/CT in familial hypocalciuric hypercalcemia type-3: a case report
por: Mukhtar, Noha N, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kb4s4eqvpp3p56ifk9lhn0qa3i